Contrary to a common assumption, making big investment gains doesn’t necessarily require constant monitoring of your portfolio or taking on extreme risks. Scaling back your… Read More »3 Stocks That Could Be Easy Wealth Builders
Investors love dividend stocks, especially those with ultra-high yields, because they offer a significant income stream and have substantial total return potential. Total return includes interest, capital gains,… Read More »4 Stocks Paying 14% Ultra-High-Yield Monthly Dividends Deliver Huge Passive Income Streams
Many investors shuffled away from high-growth tech stocks this year as the Trump administration’s unpredictable tariffs curbed the market’s appetite for riskier investments. But despite… Read More »3 High-Growth Tech Stocks That Are Screaming Buys In May
Shares of AI-driven business software developer Freshworks (NASDAQ:FRSH) surprised the market once again and trounced Wall Street estimates for the fiscal first quarter. It’s the fourth consecutive… Read More »Wall Street Forecasts 83% Stock Surge. Buy This AI Stock Under $15?
These two companies are incredibly innovative biotechs, but this hasn’t translated into strong performances recently. Both stocks have significantly lagged the market over the past three… Read More »2 Beaten-Down Stocks With Incredible Upside Potential
Growth and income investors, and those looking for dependable passive income, should pivot to quality high-yield stocks that pay dependable quarterly dividends and offer solid growth… Read More »Most Investors Don’t Realize These 4 Well-Known Stocks Also Have 7% Dividends
Stocks are at a tipping point in terms of the next 10-20% directional move and we’re heading into one of the weaker months of the… Read More »Stock Market At A Tipping Point: Watch These Key Earnings
The market is not favoring artificial intelligence (AI) stocks right now, as it is trying to de-risk itself by selling off the high-growth names that… Read More »2 Under-The-Radar AI Stocks With Market-Beating Potential
Pfizer (NYSE:PFE) is a global pharmaceutical giant that has long been a cornerstone of medical innovation and today boasts a $128 billion market cap. However, since… Read More »Prediction: 1 Biotech Stock That Could Surpass Pfizer By 2030
Thermal management technologies company Gentherm (NASDAQ:THRM) could rank among the biggest surprises this earnings season — and in a good way. No, circumstances do not appear auspicious… Read More »Gentherm: A High-Risk, High-Reward Earnings Moonshot